Isis regulatory update

The Carlsbad, Calif., company received two U.S. patents and notices of allowance for two other patent applications.

Patent No. 5,359,051 covers two nucleotides that function as small synthetic ribozymes that can be incorporated into antisense oligonucleotide drugs. ...